Cipro Hc is a drug owned by Sandoz Inc. It is protected by 2 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jun 06, 2015. Details of Cipro Hc's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5965549 | Ciprofloxacin-hydrocortisone suspension |
Jun, 2015
(9 years ago) |
Expired
|
| US5843930 | Method of treating otitis with ciprofloxacin-hydrocortisone suspension |
Jun, 2015
(9 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Cipro Hc is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Cipro Hc's family patents as well as insights into ongoing legal events on those patents.
Cipro Hc's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Cipro Hc's generic launch date based on the expiry of its last outstanding patent is estimated to be Jun 06, 2015 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Cipro Hc Generics:
There are no approved generic versions for Cipro Hc as of now.
About Cipro Hc
Cipro Hc is a drug owned by Sandoz Inc. It is used for treating otitis. Cipro Hc uses Ciprofloxacin Hydrochloride; Hydrocortisone as an active ingredient. Cipro Hc was launched by Sandoz in 1998.
Approval Date:
Cipro Hc was approved by FDA for market use on 10 February, 1998.
Active Ingredient:
Cipro Hc uses Ciprofloxacin Hydrochloride; Hydrocortisone as the active ingredient. Check out other Drugs and Companies using Ciprofloxacin Hydrochloride; Hydrocortisone ingredient
Treatment:
Cipro Hc is used for treating otitis.
Dosage:
Cipro Hc is available in suspension/drops form for otic use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| EQ 0.2% BASE;1% | SUSPENSION/DROPS | Prescription | OTIC |